ASX BIOTECH STOCKS SURGE 54% IN 2013
7 January 2014: Analysis from leading healthcare fund manager BioScience Managers has highlighted the outstanding year for biotech stocks on the ASX in 2013 with an average gain of 53.6%* across the sector. These findings compare with the All Ordinaries index that increased 14.7% over 2013 and theS&P/ASX 200 Health Care Index which increased 23.5% […]
